CAM Use Common in Cancer Patients, Survivors CAM Use Common in Cancer Patients, Survivors
At least one third of cancer patients and survivors use complementary or alternative medicines, and many do not disclose their use to their physician.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 15, 2019 Category: Primary Care Tags: Hematology-Oncology News Source Type: news

Tackling Precision Medicine with a New Kind of Decision Support
When Clynt Taylor joined Intervention Insights two years ago as CEO, the Burlington, MA-based company had already developed a platform that was being used to inform the results of molecular tests in oncology. At that time the platform was designed to take results from a molecular test and supplement that information with levels of evidence to help doctors determine which available treatment option had the highest level of evidence to support it. It was a good idea, Taylor says, but when the company started in 2011 the need for that service was greater than it is today. It wasn't long before Taylor recognized that the real ...
Source: MDDI - April 15, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Source Type: news

Eye warning: Seven signs in the eyes to watch out for - it could be cancer
CANCER symptoms can be mistaken for less serious health conditions, but failing to recognise the condition in its early stages can significantly impact your chances of survival. Seven symptoms to be aware of can appear in the eyes. (Source: Daily Express - Health)
Source: Daily Express - Health - April 15, 2019 Category: Consumer Health News Source Type: news

New pancreatic cancer treatment increases survival rates
Even with aggressive and skilled treatment, pancreatic cancer is often deadly. But, work by West Cancer Center's Dr. Axel Grothey — in partnership with doctors at the Mayo Clinic — shows that a new treatment protocol offers better outcomes for patients with the disease. Research published in the Annals of Surgery details an approach used by Grothey and his former colle agues at the Mayo Clinic. Grothey, a medical oncologist, joined the West Cancer Center& Research Institute in 2018, coming … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2019 Category: Biotechnology Authors: Jason Bolton Source Type: news

New pancreatic cancer treatment increases survival rates
Even with aggressive and skilled treatment, pancreatic cancer is often deadly. But, work by West Cancer Center's Dr. Axel Grothey — in partnership with doctors at the Mayo Clinic — shows that a new treatment protocol offers better outcomes for patients with the disease. Research published in the Annals of Surgery details an approach used by Grothey and his former colle agues at the Mayo Clinic. Grothey, a medical oncologist, joined the West Cancer Center& Research Institute in 2018, coming … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2019 Category: Pharmaceuticals Authors: Jason Bolton Source Type: news

Causes of cancer may leave 'fingerprints' in DNA, scientists say
Research raises hope that triggers of individual tumours could be pinpointedFrom smoking to alcohol, air pollution to sunlight, a host of factors in our environment can cause cancer. Now scientists say they might be able to pinpoint the culprits for individual tumours.Experts say they have managed to link particular environmental triggers with specific genetic mutations that give rise to cancer, opening up the possibility that researchers could look for clues in a tumour to deduce what triggered its formation.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 15, 2019 Category: Science Authors: Nicola Davis and agencies Tags: Cancer research Medical research Science Health Society Source Type: news

Drug Shortages Have Small Effect on Outpatient Cancer Care Drug Shortages Have Small Effect on Outpatient Cancer Care
In the outpatient setting, drug shortages have had little effect on chemotherapy treatment among adults with common cancers, say investigators.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2019 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

How to live longer: The two vegetables that can help protect the heart and lungs
HOW TO live longer: There is no secret elixir to guarantee a long life, but what you eat can greatly impact your health and affect your risk of getting struck down with diseases that may shorten your life. According to experts, these two vegetables can help protect the heart and lungs and may even help protect against cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - April 15, 2019 Category: Consumer Health News Source Type: news

27-year-old woman who was 'too young for cancer' survived a stage three tumor
Emily Piercell was just 27 when she found a lump in her breast in 2015. Doctors said it couldn't be cancer, until the Ontario, Canada native convinced them to biopsy the stage three tumor. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2019 Category: Consumer Health News Source Type: news

Colorectal Neoplasia Risk Up for Hodgkin Lymphoma Survivors
Prevalence higher for advanced adenomas, advanced serrated lesions, serrated polyposis syndrome (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 15, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Female Radiation Oncologists Receive Lower Medicare Reimbursement
Compared with male counterparts, they submit fewer charges and are reimbursed less (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 15, 2019 Category: Cancer & Oncology Tags: Oncology, Radiology, Journal, Source Type: news

Cancer-Related Insomnia: New Research Finds Effective Treatments
This study was a first of its kind. It involved a head-to-head comparison of acupuncture and cognitive behavioral therapy, enrolled patients with many different types of cancer and included nearly 30% minority participants. Previous studies focused solely on breast cancer and included 90% white participants. Limitations of the previous research make it difficult to determine if the results are applicable to patients with other cancers and people of diverse backgrounds. Cognitive Behavioral Therapy and Acupuncture Are Effective Acupuncture and cognitive behavioral therapy treatments produced clinically meaningful reduction...
Source: Asbestos and Mesothelioma News - April 15, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

TNT Approach to Pancreatic Cancer Tied to Improved Survival TNT Approach to Pancreatic Cancer Tied to Improved Survival
Upfront chemotherapy and radiation may allow for surgery and extends postoperative survival in previously unresectable patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Treatment Centers of America will withdraw from incentive deal
The company did not meet the job creation goal. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 15, 2019 Category: American Health Authors: Brian Bandell Source Type: news

Prolonged CT lung screening offers cumulative benefits
The latest results from the Multicentric Italian Lung Detection trial highlighted...Read more on AuntMinnie.comRelated Reading: CT lung screening uptake lags in rural areas CT lung screening spots cancers earlier in China CT lung screening cuts cancer mortality 51% in Japan CT lung screening reduces cancer mortality in men by 26% More CT screening may be needed for high-risk smokers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 15, 2019 Category: Radiology Source Type: news

Exclusive: Philadelphia startup breaks new ground against cancer that killed John McCain
The company, founded by Jefferson researchers, posted positive clinical trial data from an early study testing its immunotherapy vaccine in patients with glioblastoma. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 15, 2019 Category: American Health Authors: John George Source Type: news

The two-year-old who 'looks pregnant' due to a rare cancer
Cleo Keenan, two, of Blackpool, suddenly developed an abnormal swelling in her midriff earlier this year, which doctors put down to a hormone imbalance she has suffered from before. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2019 Category: Consumer Health News Source Type: news

BALVERSA ™ (erdafitinib) Receives U.S. FDA Approval for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma with Certain FGFR Genetic Alterations
(Source: Johnson and Johnson)
Source: Johnson and Johnson - April 15, 2019 Category: Pharmaceuticals Source Type: news

"Clean beauty": Bill aims to expand regulation on chemicals in cosmetics
A new bill aims to protect people from potentially dangerous chemicals found in everyday beauty products, like makeup, lotions, and shampoos. Women put an average of 168 chemicals on their face and body before they even walk out the door, while men put on an average of 85, according to the Environmental Working Group. Studies show some of those chemicals have been linked to health problems, including cancer and infertility. Anna Werner reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 15, 2019 Category: Consumer Health News Source Type: news

Female Radiation Oncologists Receive Lower Medicare Reimbursement
MONDAY, April 15, 2019 -- Female radiation oncologists submit fewer Medicare charges, bill using fewer unique codes, and receive lower Medicare payments than male radiation oncologists, according to a study published online March 22 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2019 Category: Pharmaceuticals Source Type: news

Balversa Approved for Advanced Bladder Cancer
MONDAY, April 15, 2019 -- Balversa (rdafitinib) has been approved by the U.S. Food and Drug Administration to treat adults with advanced or spreading bladder cancer caused by a genetic defect called FGFR3 or FGFR2, the agency said in a news... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2019 Category: General Medicine Source Type: news

Balversa (erdafitinib) Approved for Advanced Bladder Cancer
MONDAY, April 15, 2019 -- Balversa (erdafitinib) has been approved by the U.S. Food and Drug Administration to treat adults with advanced or spreading bladder cancer caused by a genetic defect called FGFR3 or FGFR2, the agency said in a news... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 15, 2019 Category: General Medicine Source Type: news

High-dose vitamin D shows benefit in patients with advanced colorectal cancer
Results of a small clinical trial suggest that supplementing chemotherapy with high doses of vitamin D may benefit patients with metastatic colorectal cancer by delaying progression of the disease, say scientists from Dana-Farber Cancer Institute. Prompted by the "very encouraging" results of the SUNSHINE clinical trial, the potential benefits of vitamin D supplementation in metastatic colorectal cancer will (Source: World Pharma News)
Source: World Pharma News - April 15, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Early diagnosis: Bowel cancer
Dr Clare Stephens highlights the signs and symptoms of bowel cancer and explains how the screening programme is changing. (Source: GP Online Education)
Source: GP Online Education - April 15, 2019 Category: Primary Care Tags: 15.2 Digestive Problems Source Type: news

FDA approves first targeted therapy for metastatic bladder cancer
The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy. (Source: World Pharma News)
Source: World Pharma News - April 15, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Ultrasound CADx software can stratify thyroid nodules
Although it doesn't perform as well as a sonography expert, ultrasound computer-aided...Read more on AuntMinnie.comRelated Reading: AIUM: Both thermal ablation methods work for thyroid Advanced US techniques = better thyroid nodule diagnosis AI bolsters diagnostic accuracy of thyroid ultrasound CAD helps less-experienced rads diagnose thyroid cancer Is ultrasound needed for thyroid cancer follow-up? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 15, 2019 Category: Radiology Source Type: news

Implication of Residual TILs in TNBC After Neoadjuvant Chemo Implication of Residual TILs in TNBC After Neoadjuvant Chemo
Do residual disease tumor-infiltrating lymphocyte levels help predict survival after neoadjuvant chemotherapy for TNBC?Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

OCT for Diagnosis of Basal Cell Carcinoma OCT for Diagnosis of Basal Cell Carcinoma
This review explores how optical coherence tomography, a noninvasive near-infrared light imaging technology, might improve the diagnosis and management of basal cell carcinoma.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Protective Effects of Coffee Post- Liver Transplant for HCC Protective Effects of Coffee Post- Liver Transplant for HCC
Does coffee consumption reduce the risk of hepatocellular carcinoma recurrence after liver transplantation?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Penile Cancer Epidemiology and Risk Factors Penile Cancer Epidemiology and Risk Factors
A better understanding of the epidemiology and risk factors for penile cancer may help improve the incidence rates and outcomes of this relatively rare malignancy.Current Opinion in Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2019 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Discovery of oral cancer biomarkers could save thousands of lives
(University of Otago) Oral cancer is known for its high mortality rate in developing countries, but an international team of scientists hope its latest discovery will change that.Researchers from the University of Otago, New Zealand, and the Indian Statistical Institute (ISI), Kolkata, have discovered epigenetic markers that are distinctly different in oral cancer tissues compared to the adjacent healthy tissues in patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Rutgers researchers discover crucial link between brain and gut stem cells
(Rutgers University) Researchers at Rutgers University have identified a new factor that is essential for maintaining the stem cells in the brain and gut and whose loss may contribute to anxiety and cognitive disorders and to gastrointestinal diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Some patients with imminently fatal cancer still receive treatment
(American Cancer Society) Patients who died within one month of being newly diagnosed with metastatic cancer in the United States received ineffective surgery, chemotherapy, radiation, and hormonal therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Physician-writer Siddhartha Mukherjee will be awarded the 2019 Lewis Thomas Prize
(Rockefeller University) The author of The Emperor of all Maladies, a best-selling book about cancer, will be presented with Rockefeller's science writing award at a free, public ceremony on Rockefeller's campus next month. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2019 Category: International Medicine & Public Health Source Type: news

Dr. Schmidt on AMAROS Trial Results: Radiotherapy vs Surgery of the Axilla in Breast Cancer
Cancer Network spoke with Hank Schmidt, MD, about the 10-year follow-up results of the EORTC AMAROS trial of radiotherapy vs surgery of the axilla in breast cancer patients with a positive sentinel node. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2019 Category: Cancer & Oncology Authors: Hank Schmidt, MD Source Type: news

Decoding cancer's molecular signature
(Harvard Medical School) New algorithm successfully identifies patients with a tumor-fueling DNA repair defect found in multiple cancers and treatable with a common cancer drug. Most genetic tests currently used in clinic do not reliably capture the cancer-causing defect, missing many patients who could benefit from treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Princeton scientists discover an interaction that helps cancers spread to bone
(Princeton University) A Princeton-led team of researchers have discovered a factor that promotes the spread of cancers to bone, opening the way toward treatments that could mitigate cancer's ability to colonize bone. The study by Mark Esposito, Yibin Kang and colleagues appears in the April 15 issue of Nature Cell Biology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Rare but important gene target found in many tumor types, suggesting new therapy possible
(Georgetown University Medical Center) A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

'Fingerprint database' could help scientists to identify new cancer culprits
(University of Cambridge) Scientists in Cambridge and London have developed a catalogue of DNA mutation 'fingerprints' that could help doctors pinpoint the environmental culprit responsible for a patient's tumour - including showing some of the fingerprints left in lung tumours by specific chemicals found in tobacco smoke. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Scientists get sly, use deception to fight cancer
(The Hebrew University of Jerusalem) In recent years, it's become clear that RNA-binding proteins play a major role in cancer growth. These proteins, active in all cells but especially so in cancer cells, bind to RNA molecules and accelerate cancer cell growth. Unfortunately, no cancer treatment has targeted these proteins. Until now. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Moffitt researchers identify mechanism of resistance to BRAF inhibitors in melanoma
(H. Lee Moffitt Cancer Center& Research Institute) Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these positive outcomes are not long lasting, due to the development of drug resistance and tumor recurrence. Moffitt Cancer Center researchers have discovered a mechanism by which melanoma cells become resistant to the commonly used drugs that target the BRAF protein and its signaling pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Precise decoding of breast cancer cells creates new option for treatment
(University of Zurich) Researchers at the University of Zurich and from IBM Research have investigated the vary-ing composition of cancer and immune cells in over one hundred breast tumors. They've found that aggressive tumors are often dominated by a single type of tumor cell. If certain immune cells are present as well, an immune therapy could be successful for a specific group of breast cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Russian scientists alter 3D genome using 'small molecules'
(AKSON Russian Science Communication Association) Researchers have discovered that the spatial organization of the genome can be altered using small molecule compounds which are considered as promising anti-cancer drugs. This work opens up the prospect of developing a new class of anticancer epigenetic drugs that alter the 3D genome. The results were published in Nature Communications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Scanning for cancer treatment
(Harvard University) 11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019. Recently, drug developers designed a new treatment to target the cancer's mutated genes. But, these drugs don't always work. Now, in a new study, researchers investigate both sides of the drug-body relationship to better understand why certain AML treatments--and other cancer treatments--may not work as expected. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Researcher awarded $1.17 million for cancer research
(University of Texas at Arlington) Clay Clark, professor and chair of the UTA Department of Biology, has received a four-year, $1.17 million grant from the National Institutes of Health to investigate the regulation of proteins responsible for programmed cell death. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

Housecall: Alcohol -- risks, benefits and why moderation is key
  THIS WEEK'S TOP STORIES Alcohol use: If you drink, moderation is key  It sounds like a mixed message. Drinking alcohol may offer some health benefits, especially for your heart. On the other hand, too much alcohol may damage your heart and increase your risk for certain cancers, liver disease, stroke and other serious health [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 15, 2019 Category: Databases & Libraries Source Type: news

New class of medicines shows promise
'Gene silencing' spares patients the crippling pain of intermittent porphyria Related items fromOnMedica Higher cancer risk from chronic diseases Hepatocellular carcinoma risk, cirrhosis and hepatitis C Kidney disease hits 850 million people Commonest genetic mutation causes much morbidity Prevention screening for one third of population (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 15, 2019 Category: UK Health Source Type: news

The dangers of glyphosate, the endocrine-disrupting synthetic herbicide
(Natural News) Glyphosate has been getting a lot of attention for its connection to cancer, but that’s far from the only health concern related to the weed killer. There is a long – and growing – list of dangers, but one of the biggest ones that doesn’t get a lot of attention is the fact... (Source: NaturalNews.com)
Source: NaturalNews.com - April 14, 2019 Category: Consumer Health News Source Type: news

Cancer symptoms: Three warning signs commonly mistaken for less serious health problems
CANCER symptoms are important to recognise because there ’s currently no cure for the condition. Recognising the signs as early as possible can significantly increase your chance of survival. Here are three warning signs commonly mistaken for less serious health problems. (Source: Daily Express - Health)
Source: Daily Express - Health - April 14, 2019 Category: Consumer Health News Source Type: news

Unraveling why some people get not one, not two, but many cancers
Multiple primary versions can arise by themselves, experts say. Researchers look into past treatments, environments and genetics as the culprits. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 14, 2019 Category: Consumer Health News Authors: Marlene Cimons Source Type: news